Published in

Royal Society of Chemistry, Journal of Materials Chemistry B: Materials for biology and medicine, 28(3), p. 5824-5832, 2015

DOI: 10.1039/c5tb00703h

Links

Tools

Export citation

Search in Google Scholar

Acid degradable poly(vinylcaprolactam)-based nanogels with ketal linkages for drug delivery

Journal article published in 2015 by Yang Wang, Jin Zheng, Yefei Tian, Wuli Yang ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

To improve the biocompatibility and biodegradability of nanocarriers, well-defined poly(vinylcaprolactam)-based acid degradable nanogels were fabricated for drug delivery via precipitation polymerization in water, where synthetic ketal-based 2,2-dimethacroyloxy-1-ethoxypropane (DMAEP) acted as cross-linker, and N-(2-hydroxypropyl)methacrylamide (HPMA) served as co-monomer. Expectedly, we observed that the environment temperature and pH play important roles in the performance of the nanogels. The nanogels were reduced in size upon increasing temperature and showed higher volume phase transition temperature (VPTT) with feeding higher concentration of HPMA. With the incorporation of ketal linkages, the nanogels showed accelerated degradation profiles by lowering the pH and increasing temperature of the incubation medium. When used as nanocarrier of anticancer drug Doxorubicin (DOX), compared to non-degradable nanogels with similar components, the acid-degradable nanogels displayed more effective drug controlled release behaviour, low drug leakage of DOX at neutral pH while rapid and sufficient release from the nanogels under acidic condition. The results of the cytotoxicity and hemolysis assays further highlighted that the acid-degradable nanogel showed no hemolysin but excellent viability to normal cells, and DOX-loaded nanogel presented higher proliferation inhibition against tumor cells.